Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 14 most recent Form 4 transactions.
| Jan 7 | MAZE | Maze Therapeutics, Inc. | MEXER◆ | 2,895 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | MEXER◆ | 20,744 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | SSELL | 26,920 | $39.11 | $1.1M | -100.0% | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | MEXER | 3,281 | $10.42 | $34.2K | +13.9% | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | MEXER | 2,895 | $10.42 | $30.2K | +14.0% | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | MEXER | 20,744 | $10.42 | $216.2K | — | Open the original filing on SEC.gov |
| Jan 6 | MAZE | Maze Therapeutics, Inc. | MEXER◆ | 2,493 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MAZE | Maze Therapeutics, Inc. | SSELL | 2,493 | $38.62 | $96.3K | -100.0% | Open the original filing on SEC.gov |
| Jan 6 | MAZE | Maze Therapeutics, Inc. | MEXER | 2,493 | $10.42 | $26K | — | Open the original filing on SEC.gov |
| Jan 5 | ALT | Altimmune, Inc. | PBUY | 500 | $4.24 | $2.1K | +50.0% | Open the original filing on SEC.gov |
| Sep 25, 2025 | ALT | Altimmune, Inc. | AGRANT◆ | 48,800 | — | — | — | Open the original filing on SEC.gov |
| Sep 22, 2025 | MAZE | Maze Therapeutics, Inc. | AGRANT◆ | 18,000 | — | — | — | Open the original filing on SEC.gov |